Related references
Note: Only part of the references are listed.Preclinical and clinical studies on bryostatins, a class of marine-derived protein kinase C modulators: A mini-review
Rinky Raghuvanshi et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
A multiproducer microbiome generates chemical diversity in the marine sponge Mycale hentscheli
Michael Rust et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Metagenomic Exploration of the Marine Sponge Mycale hentscheli Uncovers Multiple Polyketide-Producing Bacterial Symbionts
Mathew A. Storey et al.
mBio (2020)
PhaseIITrial of Palbociclib in Patients with Advanced Esophageal or Gastric Cancer
Thomas Benjamin Karasic et al.
ONCOLOGIST (2020)
Marine natural products
Anthony R. Carroll et al.
NATURAL PRODUCT REPORTS (2020)
Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas
Mohit Kumar Jolly et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Bryostatin-1 inhibits cell proliferation of hepatocarcinoma and induces cell cycle arrest by activation of GSK3β
Jianfeng Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Polatuzumab Vedotin: First Global Approval
Emma D. Deeks
DRUGS (2019)
A microbial factory for defensive kahalalides in a tripartite marine symbiosis
Jindong Zan et al.
SCIENCE (2019)
Marine Natural Products: A Source of Novel Anticancer Drugs
Shaden A. M. Khalifa et al.
MARINE DRUGS (2019)
Marine natural products
Anthony R. Carroll et al.
NATURAL PRODUCT REPORTS (2019)
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2018)
Anti-Tumorigenic and Anti-Metastatic Activity of the Sponge-Derived Marine Drugs Aeroplysinin-1 and Isofistularin-3 against Pheochromocytoma In Vitro
Nicole Bechmann et al.
MARINE DRUGS (2018)
(+)-Aeroplysinin-1 Modulates the Redox Balance of Endothelial Cells
Javier A. Garcia-Vilas et al.
MARINE DRUGS (2018)
Marine drugs for cancer: surfacing biotechnological innovations from the oceans
Paula Christine Jimenez et al.
CLINICS (2018)
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo Gonzalez et al.
GENES & DEVELOPMENT (2018)
Anticancer Activity of Natural Compounds from Plant and Marine Environment
Anna Lichota et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
Francesco Schettini et al.
FRONTIERS IN ONCOLOGY (2018)
Exploring the Ecology of Deep-Sea Hydrothermal Vents in a Metacommunity Framework
Lauren S. Mullineaux et al.
FRONTIERS IN MARINE SCIENCE (2018)
Fucoidan Induces ROS-Dependent Apoptosis in 5637 Human Bladder Cancer Cells by Downregulating Telomerase Activity via Inactivation of the PI3K/Akt Signaling Pathway
Min Ho Han et al.
DRUG DEVELOPMENT RESEARCH (2017)
Induction of accelerated senescence by the microtubule-stabilizing agent peloruside A
Ariane Chan et al.
INVESTIGATIONAL NEW DRUGS (2017)
EMT and MET: necessary or permissive for metastasis?
Mohit Kumar Jolly et al.
MOLECULAR ONCOLOGY (2017)
Antiproliferative cyclodepsipeptides from the marine actinomycete Streptomyces sp P11-23B downregulating the tumor metabolic enzymes of glycolysis, glutaminolysis, and lipogenesis
Xuewei Ye et al.
PHYTOCHEMISTRY (2017)
Sulfated liposaccharides inspired by telomerase inhibitor axinelloside A
Jie Guang et al.
TETRAHEDRON LETTERS (2017)
Caspase-dependent and caspase-independent induction of apoptosis in breast cancer by fucoidan via the PI3K/AKT/GSK3β pathway in vivo and in vitro
Meilan Xue et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors
Chiara Ratti et al.
CLINICAL CANCER RESEARCH (2017)
Aeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine Drug
Javier A. Garcia-Vilas et al.
MARINE DRUGS (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Cytotoxic activity of aeroplysinin-1 against colon cancer cells by promoting β-catenin degradation
Seoyoung Park et al.
FOOD AND CHEMICAL TOXICOLOGY (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib A Phase 2 Clinical Trial
Mark A. Dickson et al.
JAMA ONCOLOGY (2016)
Moving towards adaptive management of cyanotoxin-impaired water bodies
Hans W. Paerl et al.
MICROBIAL BIOTECHNOLOGY (2016)
A multicenter open-label phase II study of the efficacy and safety of palbociclib a cyclin-dependent kinases 4 and 6 inhibitor in patients with recurrent ovarian cancer.
Gottfried E. Konecny et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Exploring the ocean for new drug developments: Marine pharmacology
Harshad Malve
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2016)
Apratoxin Kills Cells by Direct Blockade of the Sec61 Protein Translocation Channel
Anja O. Paatero et al.
Cell Chemical Biology (2016)
Mitochondrial apoptosis: killing cancer using the enemy within
J. Lopez et al.
BRITISH JOURNAL OF CANCER (2015)
Anticancer Activity of Sea Cucumber Triterpene Glycosides
Dmitry L. Aminin et al.
MARINE DRUGS (2015)
Anticancer Properties of Lamellarins
Christian Bailly
MARINE DRUGS (2015)
Fucoidan from Macrocystis pyrifera Has Powerful Immune-Modulatory Effects Compared to Three Other Fucoidans
Wei Zhang et al.
MARINE DRUGS (2015)
Fucoidan and Cancer: A Multifunctional Molecule with Anti-Tumor Potential
Farzaneh Atashrazm et al.
MARINE DRUGS (2015)
Statistical Research on the Bioactivity of New Marine Natural Products Discovered during the 28 Years from 1985 to 2012
Yiwen Hu et al.
MARINE DRUGS (2015)
Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics
V. H. Le et al.
NATURAL PRODUCT REPORTS (2015)
Cancer across the tree of life: cooperation and cheating in multicellularity
C. Athena Aktipis et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2015)
What is the future of targeted therapy in rheumatology: biologics or small molecules?
Attila Mocsai et al.
BMC MEDICINE (2014)
AKT signaling is involved in fucoidan-induced inhibition of growth and migration of human bladder cancer cells
Tae-Min Cho et al.
FOOD AND CHEMICAL TOXICOLOGY (2014)
Cytotoxic Effects of Fascaplysin against Small Cell Lung Cancer Cell Lines
Gerhard Hamilton
MARINE DRUGS (2014)
Another Facet to the Anticancer Response to Lamellarin D: Induction of Cellular Senescence through Inhibition of Topoisomerase I and Intracellular Ros Production
Caroline Ballot et al.
MARINE DRUGS (2014)
Marine Sponge Derived Natural Products between 2001 and 2010: Trends and Opportunities for Discovery of Bioactives
Mohammad Ferdous Mehbub et al.
MARINE DRUGS (2014)
Marine natural products: Bryostatins in preclinical and clinical studies
Peter Kollar et al.
PHARMACEUTICAL BIOLOGY (2014)
Anti-angiogenic effects of trabectedin (Yondelis; ET-743) on human breast cancer cells
Harika Atmaca et al.
EUROPEAN CYTOKINE NETWORK (2014)
A phase II clinical trial of the CDK 4/6 inhibitor palbociclib (PD 0332991) in previously treated, advanced non-small cell lung cancer (NSCLC) patients with inactivated CDKN2A
Priya Kadambi Gopalan et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Characterization of the Bacterial Community of the Chemically Defended Hawaiian Sacoglossan Elysia rufescens
Jeanette Davis et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2013)
RCAI-61 and related 6′-modified analogs of KRN7000: Their synthesis and bioactivity for mouse lymphocytes to produce interferon-γ in vivo
Takuya Tashiro et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Giovanni Germano et al.
CANCER CELL (2013)
Synthesis and biological activity of hydroxylated analogues of KRN7000 (α-galactosylceramide)
Masao Shiozaki et al.
CARBOHYDRATE RESEARCH (2013)
CD30: from basic research to cancer therapy
Hiromi Muta et al.
IMMUNOLOGIC RESEARCH (2013)
Brown seaweed fucoidan: Biological activity and apoptosis, growth signaling mechanism in cancer
Kalimuthu Senthilkumar et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2013)
Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4-Amplified Well-Differentiated or Dedifferentiated Liposarcoma
Mark A. Dickson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Fucoidan induces G1 phase arrest and apoptosis through caspases-dependent pathway and ROS induction in human breast cancer MCF-7 cells
Amal M. Banafa et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2013)
Isolation and First Total Synthesis of PM050489 and PM060184, Two New Marine Anticancer Compounds
Maria Jesus Martin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling
Yuqing Liu et al.
LIVER INTERNATIONAL (2013)
Evading apoptosis in cancer
Kaleigh Fernald et al.
TRENDS IN CELL BIOLOGY (2013)
Structure-Activity Relationship Studies of Novel Glycosphingolipids That Stimulate Natural Killer T-Cells
Takuya Tashiro
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2012)
A phase 1 trial of E7974 administered on day 1 of a 21-day cycle in patients with advanced solid tumors
Caio M. Rocha-Lima et al.
CANCER (2012)
Cyclin dependent kinases in cancer Potential for therapeutic intervention
Miriam Canavese et al.
CANCER BIOLOGY & THERAPY (2012)
Anticancer Properties and Mechanisms of Fucoidan on Mouse Breast Cancer In Vitro and In Vivo
Meilan Xue et al.
PLOS ONE (2012)
Fucoidan from Seaweed Fucus vesiculosus Inhibits Migration and Invasion of Human Lung Cancer Cell via PI3K-Akt-mTOR Pathways
Hyunkyoung Lee et al.
PLOS ONE (2012)
Mechanisms of telomere loss and their consequences for chromosome instability
Keiko Muraki et al.
FRONTIERS IN ONCOLOGY (2012)
Palmerolide macrolides from the Antarctic tunicate Synoicum adareanum
Jaime H. Noguez et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Basic and Therapeutic Aspects of Angiogenesis
Michael Potente et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Marine natural products: a new wave of drugs?
Rana Montaser et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Fucoidan from Sargassum sp and Fucus vesiculosus reduces cell viability of lung carcinoma and melanoma cells in vitro and activates natural killer cells in mice in vivo
Marcel Tutor Ale et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2011)
FRESH FROM THE PIPELINE Eribulin mesylate
Timothy K. Huyck et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Fucoidan present in brown algae induces apoptosis of human colon cancer cells
Eun Ji Kim et al.
BMC GASTROENTEROLOGY (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
A Review of Trabectedin (ET-743): A Unique Mechanism of Action
Maurizio D'Incalci et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas.
Anas Younes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma
Salvador Martin-Algarra et al.
EUROPEAN JOURNAL OF CANCER (2009)
A Phase I-II Study of α-Galactosylceramide-Pulsed IL-2/GM-CSF-Cultured Peripheral Blood Mononuclear Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer
Shinichiro Motohashi et al.
JOURNAL OF IMMUNOLOGY (2009)
Tubulin-based antimitotic mechanism of E7974, a novel analogue of the marine sponge natural product hemiasterlin
Galina Kuznetsov et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Drug development from marine natural products
Tadeusz F. Molinski et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Phase I Pharmacokineitic and Pharmacodynamic Study of LAQ824, a Hydroxamate Histone Deacetylase Inhibitor with a Heat Shock Protein-90 Inhibitory Profile, in Patients with Advanced Solid Tumors
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells
Mee Young Ahn et al.
GYNECOLOGIC ONCOLOGY (2008)
A unique mode of microtubule stabilization induced by peloruside A
J. Torin Huzil et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Total synthesis and molecular target of largazole, a histone deacetylase inhibitor
Yongcheng Ying et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Structure and activity of largazole, a potent antiproliferative agent from the Floridian marine cyanobacterium Symploca sp.
Kanchan Taori et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Aminopeptidase N/CD13 induces angiogenesis through interaction with a pro-angiogenic protein, galectin-3
Eunju Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds
Albana Cumashi et al.
GLYCOBIOLOGY (2007)
A phase 2 study of TZT-1027, administered weekly to patients with advanced non-small cell lung cancer following treatment with platinum-based chemotherapy
Gregory J. Riely et al.
LUNG CANCER (2007)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Asterosaponin 1, a cytostatic compound from the starfish Culcita novaeguineae, functions by inducing apoptosis in human glioblastoma U87MG cells
Guang Cheng et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Palmerolide A, a cytotoxic macrolide from the Antarctic tunicate Synoicum adareanum
T Diyabalanage et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Assessment of in vitro and in vivo activities in the National Cancer Institute's anticancer screen with respect to chemical structure, target specificity, and mechanism of action
RL Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Cancer cell mitochondria are direct proapoptotic targets for the marine antitumor drug lamellarin D
J Kluza et al.
CANCER RESEARCH (2006)
A functional genomics approach to the mode of action of apratoxin A
H Luesch et al.
NATURE CHEMICAL BIOLOGY (2006)
Asterosaponins from the starfish Culcita novaeguineae and their bioactivities
HF Tang et al.
FITOTERAPIA (2006)
Variolin B and its derivate deoxy-variolin B: New marine natural compounds with cyclin-dependent kinase inhibitor activity
M Simone et al.
EUROPEAN JOURNAL OF CANCER (2005)
Phase II trials of dolastatin-10 in advanced pancreaticobiliary cancers
HL Kindler et al.
INVESTIGATIONAL NEW DRUGS (2005)
Axinelloside A, an unprecedented highly sulfated lipopolysaccharide inhibiting telomerase, from the marine sponge, Axinella infundibula
K Warabi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Phase II trial of dolastatin-10 in patients with advanced breast cancer
EA Perez et al.
INVESTIGATIONAL NEW DRUGS (2005)
Philinopside A, a novel marine-derived compound possessing dual anti-angiogenic and anti-tumor effects
YG Tong et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Spatial and temporal variability of cytotoxic metabolites in populations of the New Zealand sponge Mycale hentscheli
M Page et al.
JOURNAL OF CHEMICAL ECOLOGY (2005)
The microtubule stabilizing agent discodermolide is a potent inducer of accelerated cell senescence
LE Klein et al.
CELL CYCLE (2005)
The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584
DZ Qian et al.
CANCER RESEARCH (2004)
Induction of morphological and biochemical apoptosis following prolonged mitotic blockage by halichondrin B macrocyclic ketone analog E7389
G Kuznetsov et al.
CANCER RESEARCH (2004)
Biosynthetic pathway and gene cluster analysis of curacin A, an antitubulin natural product from the tropical marine cyanobacterium Lyngbya majuscula
ZX Chang et al.
JOURNAL OF NATURAL PRODUCTS (2004)
Death by design: apoptosis, necrosis and autophagy
AL Edinger et al.
CURRENT OPINION IN CELL BIOLOGY (2004)
Chemical defense of hydrothermal vent and hydrocarbon seep organisms: a preliminary assessment using shallow-water consumers
CE Kicklighter et al.
MARINE ECOLOGY PROGRESS SERIES (2004)
Antiangiogenic activity of aplidine, a new agent of marine origin
G Taraboletti et al.
BRITISH JOURNAL OF CANCER (2004)
Microtubule-targeted anticancer agents and apoptosis
KN Bhalla
ONCOGENE (2003)
Molecular basis of angiogenesis and cancer
T Tonini et al.
ONCOGENE (2003)
Antitumor activity of TZT-1027 (Soblidotin) against vascular endothelial growth factor-secreting human lung cancer in vivo
T Natsume et al.
CANCER SCIENCE (2003)
Drugs from the deep: marine natural products as drug candidates
B Haefner
DRUG DISCOVERY TODAY (2003)
The molecular pharmacology of symplostatin 1: A new antimitotic dolastatin 10 analog
SL Mooberry et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study
MA Hoffman et al.
GYNECOLOGIC ONCOLOGY (2003)
Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4
M Broggini et al.
LEUKEMIA (2003)
Phase II study of dolastatin-10 as first-line treatment for advanced colorectal cancer
ED Saad et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2002)
Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine
E Erba et al.
BRITISH JOURNAL OF CANCER (2002)
Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge
S Rodríguez-Nieto et al.
FASEB JOURNAL (2001)
Chemical defenses of the sacoglossan mollusk Elysia rufescens and its host alga Bryopsis sp.
MA Becerro et al.
JOURNAL OF CHEMICAL ECOLOGY (2001)
Evidence for the biosynthesis of bryostatins by the bacterial symbiont Candidatus Endobugula sertula of the bryozoan Bugula neritina
SK Davidson et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2001)
Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair
Y Takebayashi et al.
NATURE MEDICINE (2001)
Growth factor-dependent signaling and cell cycle progression
SM Jones et al.
CHEMICAL REVIEWS (2001)
Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1
H Luesch et al.
JOURNAL OF NATURAL PRODUCTS (2001)
Involvement of oxygen radicals in cytarabine-induced apoptosis in human polymorphonuclear cells
M Iacobini et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Halenaquinone, a novel phosphatidylinositol 3-kinase inhibitor from a marine sponge, induces apoptosis in PC12 cells
H Fujiwara et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Cryptophycin-induced hyperphosphorylation of Bcl-2, cell cycle arrest and growth inhibition in human H460NSCLC cells
K Lu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
Dolastatin-10 in metastatic melanoma: A phase II and pharmokinetic trial of the california cancer consortium
K Margolin et al.
INVESTIGATIONAL NEW DRUGS (2001)
Inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin, a marine natural product
R Soni et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
TZT-1027, an antimicrotubule agent, attacks tumor vasculature and induces tumor cell death
M Otani et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2000)
Human invariant Vα24+ natural killer T cells activated by α-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells
A Nicol et al.
IMMUNOLOGY (2000)
Peloruside A:: A potent cytotoxic macrolide isolated from the New Zealand marine sponge Mycale sp.
LM West et al.
JOURNAL OF ORGANIC CHEMISTRY (2000)
Share Paper
